BNB PLUS CORP (BNBX) Stock Price & Overview
NASDAQ:BNBX • US03815U6073
The current stock price of BNBX is 0.753 USD. Today BNBX is down by -1.68%. In the past month the price decreased by -18.61%.
BNBX Key Statistics
- Market Cap
- 4.104M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -272.19
- Dividend Yield
- N/A
BNBX Stock Performance
BNBX Stock Chart
BNBX Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to BNBX.
BNBX Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to BNBX. BNBX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
BNBX Earnings
BNBX Forecast & Estimates
For the next year, analysts expect an EPS growth of 77.08% and a revenue growth 40% for BNBX
BNBX Groups
Sector & Classification
BNBX Financial Highlights
Over the last trailing twelve months BNBX reported a non-GAAP Earnings per Share(EPS) of -272.19. The EPS increased by 92.17% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -340.95% | ||
| ROE | -374.65% | ||
| Debt/Equity | 0 |
BNBX Ownership
BNBX Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 20.25 | 189.444B | ||
| DHR | DANAHER CORP | 23.19 | 140.579B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 135.13 | 44.937B | ||
| A | AGILENT TECHNOLOGIES INC | 17.39 | 32.974B | ||
| WAT | WATERS CORP | 20.83 | 29.986B | ||
| IQV | IQVIA HOLDINGS INC | 13.54 | 29.973B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 26.3 | 25.384B | ||
| ILMN | ILLUMINA INC | 23.41 | 19.002B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 28.89 | 17.865B | ||
| MEDP | MEDPACE HOLDINGS INC | 27.05 | 13.581B | ||
| RVTY | REVVITY INC | 16.68 | 10.298B | ||
| TEM | TEMPUS AI INC-CL A | N/A | 9.353B | ||
| CRL | CHARLES RIVER LABORATORIES | 15.33 | 8.713B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About BNBX
Company Profile
BNB Plus Corp. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. The company is headquartered in Stony Brook, New York and currently employs 26 full-time employees. The company went IPO on 2001-08-24. The Company’s differentiated strategy blends sophisticated DeFi yield generation with Binance-native opportunities, unlocking access to high-performance digital assets for investors traditionally excluded from the space. The firm is also commercializing proprietary nucleic acid production solutions for the biopharmaceutical and diagnostics markets.
Company Info
IPO: 2001-08-24
BNB PLUS CORP
50 Health Sciences Drive
Stony Brook NEW YORK US
Employees: 26
Phone: 16312408800
BNB PLUS CORP / BNBX FAQ
Can you describe the business of BNB PLUS CORP?
BNB Plus Corp. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. The company is headquartered in Stony Brook, New York and currently employs 26 full-time employees. The company went IPO on 2001-08-24. The Company’s differentiated strategy blends sophisticated DeFi yield generation with Binance-native opportunities, unlocking access to high-performance digital assets for investors traditionally excluded from the space. The firm is also commercializing proprietary nucleic acid production solutions for the biopharmaceutical and diagnostics markets.
What is the current price of BNBX stock?
The current stock price of BNBX is 0.753 USD. The price decreased by -1.68% in the last trading session.
Does BNBX stock pay dividends?
BNBX does not pay a dividend.
What is the ChartMill technical and fundamental rating of BNBX stock?
BNBX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the expected growth for BNBX stock?
The Revenue of BNB PLUS CORP (BNBX) is expected to grow by 40% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the number of employees for BNB PLUS CORP?
BNB PLUS CORP (BNBX) currently has 26 employees.
What is the outstanding short interest for BNB PLUS CORP?
The outstanding short interest for BNB PLUS CORP (BNBX) is 1.51% of its float.